Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-05-12

FDA Approved: XERESE — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental application for XERESE, a topical product containing acyclovir and hydrocortisone, from Bausch Health US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XERESE (ACYCLOVIR AND HYDROCORTISONE)

Snippet

SUPPL AP for XERESE (ACYCLOVIR AND HYDROCORTISONE)